At present, studies on NDC1 mainly are involved in lung cancer, colon cancer, cervical cancer, esophageal cancer and hepatocellular carcinoma [8–13], and there was no previous report in pancreatic cancers. This evidence concerns the gene NDC1 and esophageal cancer.